Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-28T10:45:09.772Z Has data issue: false hasContentIssue false

A Case of Healthcare-Associated, Multidrug-Resistant Tuberculosis in Austria: Reconsidering the Value of Cohorting of Patients with Culture-Positive Tuberculosis

Published online by Cambridge University Press:  02 January 2015

Alexander Indra
Affiliation:
Austrian Agency for Health and Food Safety, Vienna
Barbara Robl
Affiliation:
Austrian Agency for Health and Food Safety, Vienna
Ingrid Aumüller
Affiliation:
Austrian Agency for Health and Food Safety, Vienna
Eva Magnet
Affiliation:
Public Health Authority of the Province of Oberösterreich, Linz, Austria
Stefan Meusburger
Affiliation:
Public Health Authority of the Province of Oberösterreich, Linz, Austria
Franz Allerberger*
Affiliation:
Austrian Agency for Health and Food Safety, Vienna
*
Austrian Agency for Health and Food Safety, Spargelfeldstr. 191, A-1220 Vienna, Austria ([email protected])

Abstract

Cohorting of patients with culture-positive tuberculosis is still widely practiced in Austria, a country where approximately 1% of Mycobacterium tuberculosis isolates are multidrug resistant. Cohorting of patients with tuberculosis prior to determination of drug susceptibility is unacceptable because M. tuberculosis superinfection can occur.

Type
Concise Communication
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Clark, CM, Driver, CR, Munsiff, SS, et al.Universal genotyping in tuberculosis control program, New York City, 2001-2003. Emerg Infect Dis 2006;12:719724.Google Scholar
2.Brudey, K, Driscoll, IR, Rigout, L, et al.Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiology 2006;6:2340.Google Scholar
3.Pavlic, M, Allerberger, F, Dierich, MP, Prodinger, WM. Simultaneous infection with two drug susceptible Mycobacterium tuberculosis strains in an immunocompetent host. J Clin Microbiol 1999;37:41564157.Google Scholar
4.Prodinger, WM, Pavlic, M, Allerberger, F. Molekulare epidemiologie der tuberkulose: fünf jahre DNA-fingerprinting in Westösterreich. In: Janata, O, Reisinger, E, eds. Infektiologie Aktuelle Aspekte Jahrbuch 2000. Vienna: Österreichische Verlagsgesellscaft; 2000:193203.Google Scholar
5.Larson, JL, Lambert, L, Stricof, RL, Driscoll, J, McGarry, MA, Ridzon, R. Potential nosocomial exposure to Mycobacterium tuberculosis from a bronchoscope. Infect Control Hosp Epidemiol 2003;24:825830.Google Scholar
6.Gori, A, Bandera, A, Marchetti, A, et al.Spoligotyping and Mycobacterium tuberculosis. Emerg Infect Dis 2005;11:12421248.Google Scholar
7.Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54(RR-17):1141.Google Scholar
8.Brewer, TF. Tuberculosis. In: Wenzel, R, Brewer, T, Butzler, J-P, eds. A Guide to Infection Control in the Hospital. 3rd ed. Boston: International Society for Infectious Diseases; 2004:131136.Google Scholar
9.Centers for Disease Control and Prevention. Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep 2005;54:181.Google Scholar
10.Center for Pulmonary and Infectious Disease Control. Tuberculosis at a glance: a reference for practitioners on basic issues regarding tuberculosis. Tyler, TX: The University of Texas Health Center at Tyler; 2004. Available at: http://www.uthct.edu/files/pdf/cpidc_tbataglancefeb2004.pdf. Accessed May 8, 2006.Google Scholar